Walleye Capital
ISEE

Walleye Capital’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Walleye Capital’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-65,805
Closed -$2.59M – 5590
2023
Q2 		$2.59M Sell
65,805
-77,773
-54% -$2.75M 0.01% 1158
2023
Q1 		$3.49M Sell
143,578
-311,237
-68% -$6.81M 0.05% 439
2022
Q4 		$9.74M Sell
454,815
-187,136
-29% -$3.99M 0.18% 126
2022
Q3 		$11.5M Buy
641,951
+28,786
+5% +$378K 0.22% 90
2022
Q2 		$5.9M Buy
613,165
+81,020
+15% +$1.02M 0.16% 145
2022
Q1 		$8.96M Buy
532,145
+339,172
+176% +$5.01M 0.24% 86
2021
Q4 		$3.23M Buy
+192,973
New +$3.16M 0.1% 221
2021
Q3 		– Sell
-62,150
Closed -$392 – 1893
2021
Q2 		$392 Buy
+62,150
New +$401K 0.01% 852
2020
Q2 		– Sell
-16,060
Closed -$55K – 1069
2020
Q1 		$55K Buy
+16,060
New +$93.9K 0.01% 679

Walleye Capital's ISEE Position: Q3 2023 in Review

Walleye Capital sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 65,805 shares — an estimated $2.59M sold.

Walleye Capital first reported a position in ISEE in Q1 2020 and held it in 9 quarters. The position peaked at $11.5M in Q3 2022. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Walleye Capital reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Walleye Capital sold 65,805 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $2.59M.
  • Walleye Capital first reported a position in IVERIC bio, Inc. Common Stock in Q1 2020 and held it in 9 quarters.
  • Walleye Capital's IVERIC bio, Inc. Common Stock position peaked at $11.5M in Q3 2022.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Walleye Capital's 13F filing for Q3 2023, filed 14 Nov 2023.